Showing results (241-250 of 308) with videos related to
Sort By:
Pageof 31
Biomedicines|July 29, 2025
Toll-like Receptor 9 Mediates Epstein-Barr Virus-Aggravated Inflammation in a Mouse Model of Inflammatory Bowel DiseaseHassan F Nour Eddine, Aya M Kassem, Zahraa Salhab, et al.The American Journal of Gastroenterology|May 8, 2024
Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B VaccinationChristian Karime, Cecily N Black, Pedro Cortes, et al.Annals of Gastroenterology|September 5, 2022
Significance of granulomas in the outcomes of Crohn's disease patientsMarie Christelle Saade, Hisham Wehbe, Fadi H Mourad, et al.Crohn'S & Colitis 360|May 25, 2026
Safety of biologics and Janus kinase inhibitors in inflammatory bowel disease patients with low cardiovascular riskParaj Patel, Omair Iqbal, Divyanshu Mohananey, et al.Cancer Immunology Research|December 14, 2019
Cross-talk between Colon Cells and Macrophages Increases ST6GALNAC1 and MUC1-sTn Expression in Ulcerative Colitis and Colitis-Associated Colon CancerMichael Kvorjak, Yasmine Ahmed, Michelle L Miller, et al.Inflammatory Bowel Diseases|December 13, 2024
Gender and Sex Differences in Abdominal Pain, Fatigue, And Psychological Symptoms Among Adults with Inflammatory Bowel Disease: A Network AnalysisKendra Kamp, Pei-Lin Yang, Chi-Shan Tsai, et al.Journal of Clinical Gastroenterology|October 21, 2015
Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease CohortIoannis E Koutroubakis, Claudia Ramos-Rivers, Miguel Regueiro, et al.Southern Medical Journal|February 8, 2011
Prophylaxis with ertapenem in patients with obstructive jaundice undergoing endoscopic retrograde cholangiopancreatography: safety, efficacy, and biliary penetrationAla I Sharara, Ihab I El Hajj, Mohammad Mroueh, et al.The American Journal of Gastroenterology|September 28, 2004
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's diseaseWilliam J Sandborn, Stephen Hanauer, Edward V Loftus, et al.Inflammatory Bowel Diseases|May 2, 2015
The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel DiseaseIoannis E Koutroubakis, Claudia Ramos-Rivers, Miguel Regueiro, et al.Pageof 31